Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Schey

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 29, 2020
Cannabinoid hyperemesis syndrome: the conundrum is here to stayRon Schey
Digestive Diseases and Sciences|August 5, 2017
Understanding the Differences Between Gastroparesis and Gastroparesis-Like Syndrome: Filling a GaPing Hole?Jonathan Gotfried, Ron Schey
Therapeutic Advances in Chronic Disease|March 3, 2015
Lubiprostone in constipation: clinical evidence and place in therapyNicholas Wilson, Ron Schey
Gastroenterology Clinics of North America|July 29, 2020
Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel SyndromeLauren Stemboroski, Ron Schey
Digestive Diseases and Sciences|October 2, 2017
Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation DisordersJonathan Gotfried, Ron Schey
Digestive Diseases and Sciences|September 25, 2012
Eosinophilic esophagitis: current treatmentMatthew Redd, Ron Schey
Clinical Medicine Insights. Gastroenterology|May 17, 2014
Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipationMahmoud Soubra, Ron Schey
Current Treatment Options in Gastroenterology|October 5, 2016
Cannabinoids and GI Disorders: Endogenous and ExogenousZachary Wilmer Reichenbach, Ron Schey
Expert Opinion on Pharmacotherapy|July 21, 2015
Current advances in treatment of gastroparesisMark Malamood, Henry Parkman, Ron Schey
Current Gastroenterology Reports|February 27, 2015
The role of cannabinoids in regulation of nausea and vomiting, and visceral painZubair Malik, Daniel Baik, Ron Schey
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 29, 2020
Cannabinoid hyperemesis syndrome: the conundrum is here to stayRon Schey
Digestive Diseases and Sciences|August 5, 2017
Understanding the Differences Between Gastroparesis and Gastroparesis-Like Syndrome: Filling a GaPing Hole?Jonathan Gotfried, Ron Schey
Therapeutic Advances in Chronic Disease|March 3, 2015
Lubiprostone in constipation: clinical evidence and place in therapyNicholas Wilson, Ron Schey
Gastroenterology Clinics of North America|July 29, 2020
Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel SyndromeLauren Stemboroski, Ron Schey
Digestive Diseases and Sciences|October 2, 2017
Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation DisordersJonathan Gotfried, Ron Schey
Digestive Diseases and Sciences|September 25, 2012
Eosinophilic esophagitis: current treatmentMatthew Redd, Ron Schey
Clinical Medicine Insights. Gastroenterology|May 17, 2014
Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipationMahmoud Soubra, Ron Schey
Current Treatment Options in Gastroenterology|October 5, 2016
Cannabinoids and GI Disorders: Endogenous and ExogenousZachary Wilmer Reichenbach, Ron Schey
Expert Opinion on Pharmacotherapy|July 21, 2015
Current advances in treatment of gastroparesisMark Malamood, Henry Parkman, Ron Schey
Current Gastroenterology Reports|February 27, 2015
The role of cannabinoids in regulation of nausea and vomiting, and visceral painZubair Malik, Daniel Baik, Ron Schey
Pageof 7